Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-2-12
pubmed:abstractText
Suboxone (Buprenorphine/naloxone) is a novel drug used in opiate substitution therapy. In Hungary, it was introduced in November 2007. Suboxone is a product for sublingual administration containing the partial mu-receptor agonist buprenorphine and antagonist naloxone in a 4:1 ratio.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1419-8711
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
249-57
pubmed:meshHeading
pubmed-meshheading:20150662-Adult, pubmed-meshheading:20150662-Anxiety, pubmed-meshheading:20150662-Buprenorphine, pubmed-meshheading:20150662-Depression, pubmed-meshheading:20150662-Drug Combinations, pubmed-meshheading:20150662-Female, pubmed-meshheading:20150662-Humans, pubmed-meshheading:20150662-Hungary, pubmed-meshheading:20150662-Irritable Mood, pubmed-meshheading:20150662-Male, pubmed-meshheading:20150662-Naloxone, pubmed-meshheading:20150662-Narcotic Antagonists, pubmed-meshheading:20150662-Narcotics, pubmed-meshheading:20150662-Opioid-Related Disorders, pubmed-meshheading:20150662-Psychiatric Status Rating Scales, pubmed-meshheading:20150662-Questionnaires, pubmed-meshheading:20150662-Stress, Psychological, pubmed-meshheading:20150662-Substance Abuse Treatment Centers, pubmed-meshheading:20150662-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Early experience with Suboxone maintenance therapy in Hungary.
pubmed:affiliation
Eötvös Loránd University, Institutional Group on Addiction Research, Budapest, Hungary. demetrovics@t-online.hu
pubmed:publicationType
Journal Article